Herbal drugs against cardiovascular disease: Traditional medicine and modern development

Drug Discovery Today

Volumn 20, Issue 9, 2015, Pages 1074-1086

  Li, Lingjun ^a   Zhou, Xiuwen ^a   Li, Na ^a   Sun, Miao ^a   Lv, Juanxiu ^a   Xu, Zhice ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTIN; CRATAEGUS EXTRACT; EUCOMMIA ULMOIDES EXTRACT; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; ION CHANNEL; NITRIC OXIDE; PANAX NOTOGINSENG EXTRACT; SALVIA MILTIORRHIZA EXTRACT; TETRAMETHYLPYRAZINE; CARDIOVASCULAR AGENT; PLANT MEDICINAL PRODUCT;

ALTERNATIVE MEDICINE; APOPTOSIS; CARDIOVASCULAR DISEASE; CELL DAMAGE; CELL MIGRATION; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; DATA BASE; DRUG MECHANISM; HEART VENTRICLE HYPERTROPHY; HERB DRUG INTERACTION; HERBAL MEDICINE; HUMAN; HYPERTENSION; INFLAMMATION; INOTROPISM; ISCHEMIC HEART DISEASE; NONHUMAN; OXIDATIVE STRESS; REVIEW; SMOOTH MUSCLE FIBER; ANIMAL; CARDIOVASCULAR DISEASES; CHEMISTRY; DRUG DESIGN; ISOLATION AND PURIFICATION; MEDICINAL PLANT; PHYTOTHERAPY; PROCEDURES; TRADITIONAL MEDICINE;

ANIMALS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; DRUG DESIGN; HUMANS; MEDICINE, TRADITIONAL; PHYTOTHERAPY; PLANT PREPARATIONS; PLANTS, MEDICINAL;

EID: 84941022736     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2015.04.009     Document Type: Review

References (158)

1. J.H. Vogel, and et al. Integrating complementary medicine into cardiovascular medicine J. Am. Coll. Cardiol. 46 2005 184 221
2. R. Shouk, and et al. Mechanisms underlying the antihypertensive effects of garlic bioactives Nutr. Res. 34 2014 106 115
3. Z.Y. Chen, and et al. Anti-hypertensive nutraceuticals and functional foods J. Agric. Food Chem. 57 2009 4485 4499
4. T.O. Cheng Danshen: a versatile Chinese herbal drug for the treatment of coronary heart disease Int. J Cardiol. 113 2006 437 438
5. X. Li, and et al. Network pharmacology study on major active compounds of Fufang Danshen formula Zhongguo Zhong Yao Za Zhi 36 2011 2911 2915
6. T.Y. Yang, and et al. A randomized, double-blind, placebo-controlled study to evaluate the efficacy and tolerability of Fufang Danshen (Salvia miltiorrhiza) as add-on antihypertensive therapy in Taiwanese patients with uncontrolled hypertension Phytother. Res. 26 2012 291 298
7. D.D. Kim, and et al. Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension Am. J. Physiol. Heart Circ. Physiol. 292 2007 H2131 H2137
8. Z.X. Liu, and C.H. Wu Therapeutic effect of Danshen (Salvia miltiorrhiza) on moderate pregnancy-induced hypertension Occupation Health 20 2004 139 140 (in Chinese)
9. C.P. Mao, and et al. The effect of tanshinone IIA on the cardiovascular system in ovine fetus in utero Am. J. Chin. Med. 37 2009 1031 1044
10. K. Ried, and et al. Effect of garlic on blood pressure: a systematic review and meta-analysis BMC Cardiovasc. Disord. 8 2008 13
11. A. Rohner, and et al. A systematic review and metaanalysis on the effects of garlic preparations on blood pressure in individuals with hypertension Am. J. Hypertens. 28 2015 414 423
12. A.D. Kaye, and et al. Analysis of responses of allicin, a compound from garlic, in the pulmonary vascular bed of the cat and in the rat Eur. J. Pharmacol. 276 1995 21 26
13. K.K. Al-Qattan, and et al. Thromboxane-B2, prostaglandin-E2 and hypertension in the rat 2-kidney 1-clip model: a possible mechanism of the garlic induced hypotension Prostag. Leukotr. Ess. 64 2001 5 10
14. H. Mahmoud, and et al. Garlic extract reduces serum angiotensin converting enzyme (ACE) activity in nondiabetic and streptozotocin-diabetic rats Pathophysiology 14 2007 109 112
15. V. Dhawan, and S. Jain Garlic supplementation prevents oxidative DNA damage in essential hypertension Mol. Cell Biochem. 275 2005 85 94
16. C. Castro, and et al. Garlic components inhibit angiotensin II-induced cell-cycleprogression and migration: involvement of cell-cycle inhibitor p27 (Kip1) and mitogen-activated protein kinase Mol. Nutr. Food Res. 54 2010 781 787
17. S. Asgary, and et al. Antihypertensive effect of Iranian Crataegus curvisepala Lind.: a randomized, double-blind study Drugs Exp. Clin. Res. 30 2004 221 225
18. A.F. Walker, and et al. Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: a randomised controlled trial Br. J. Gen. Pract. 56 2006 437 443
19. Z.C. Koçyildiz, and et al. Crataegus tanacetifolia leaf extract prevents L-NAME-induced hypertension in rats: a morphological study Phytother. Res. 20 2006 66 70
20. W. Peters, and et al. Nanomechanics and sodium permeability of endothelial surface layer modulated by hawthorn extract WS1442 PLoS One 7 2012 e29972
21. F. Greenway, and et al. A clinical trial testing the safety and efficacy of a standardized Eucommia ulmoides Oliver bark extract to treat hypertension Altern. Med. Rev. 16 2011 338 347
22. L.F. Luo, and et al. Antihypertensive effect of Eucommia ulmoides Oliv. extracts in spontaneously hypertensive rats J. Ethnopharmacol. 129 2010 238 243
23. L. Li, and et al. Protective effects of Eucommia lignans against hypertensive renal injury by inhibiting expression of aldose reductase J. Ethnopharmacol. 139 2012 454 611
24. J. Gu, and et al. Effects of lignans extracted from Eucommia ulmoides and aldose reductase inhibitor epalrestat on hypertensive vascular remodeling J. Ethnopharmacol. 133 2011 6 13
25. Z.Y. Li, and et al. Lignans from the bark of Eucommia ulmoides inhibited Ang II-stimulated extracellular matrix biosynthesis in mesangial cells Chin. Med. 9 2014 8
26. S.Z. Hoe, and et al. Inhibition of angiotensin-converting enzyme activity by a partially purified fraction of Gynura procumbens in spontaneously hypertensive rats Med. Princ. Pract. 16 2007 203 208
27. M.J. Kim, and et al. Antihypertensive effects of Gynura procumbens extract in spontaneously hypertensive rats J. Med. Food 9 2006 587 590
28. H.K. Ng, and et al. Potassium channel openers and prostacyclin play a crucial role in mediating the vasorelaxant activity of Gynura procumbens BMC Complement Altern. Med. 13 2013 188
29. D.J. Becker, and et al. Red yeast rice for dyslipidemia in statin-intolerant patients: a randomize trial Ann. Intern. Med. 150 2009 830 839 W147-149
30. P. Ye, and et al. Effect of xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction: a subgroup analysis of elderly subjects from the China Coronary Secondary Prevention Study J. Am. Ger. Soc. 55 2007 1015 1022
31. O. Erdogrul, and S. Azirak A review on the red yeast rice (Monascus purpureus) KSU J. Sci. Eng. 8 2005 10 15
32. M.H. Moghadasian, and J.J. Frohlich Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis: clinical and experimental evidence Am. J. Med. 107 1999 588 594
33. K. Ried, and et al. Effect of garlic on serum lipids: an updated meta-analysis Nutr. Rev. 71 2013 282 299
34. Y.C. Cheng, and et al. Garlic oil attenuates the cardiac apoptosis in hamster-fed with hypercholesterol diet Food Chem. 136 2013 1296 1302
35. M.J. Kim, and H.K. Kim Effect of garlic on high fat induced obesity Acta Biol. Hung. 62 2011 244 254
36. Y. Lin, and et al. Triterpenic acids present in hawthorn lower plasma cholesterol by inhibiting intestinal ACAT activity in hamsters Evid. Based Complement Alternat. Med. 2011 801272
37. R. Benfante, and et al. Do coronary heart disease risk factors measured in the elderly have the same predictive roles as in the middle aged. Comparisons of relative and attributable risks Ann. Epidemiol. 2 1992 273 282
38. E. Koch, and et al. Standardized extracts from hawthorn leaves and flowers in the treatment of cardiovascular disorders - preclinical and clinical studies Planta Med. 77 2011 1123 1128
39. E. Koch, and et al. Hawthorn P.M. Coates, Encyclopedia of Dietary Supplements 2nd edn 2010 Informa Healthcare 411 422
40. C.J. Holubarsch, and et al. The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial Eur. J. Heart Fail. 10 2008 1255 1263
41. Y. Zhang, and et al. Hawthorn fruit attenuates atherosclerosis by improving the hypolipidemic and antioxidant activities in apolipoprotein E-deficient mice J. Atheroscler. Thromb. 21 2014 119 128
42. E.S. Kao, and et al. Anti-inflammatory potential of flavonoid contents from dried fruit of Crataegus pinnatifida in vitro and in vivo J. Agric. Food Chem. 53 2005 430 436
43. H.S. Hwang, and et al. Effects of hawthorn on cardiac remodeling and left ventricular dysfunction after 1 month of pressure overload-induced cardiac hypertrophy in rats Cardiovasc. Drugs Ther. 22 2008 19 28
44. E.A. Willer, and et al. The vascular barrier-protecting hawthorn extract WS(R) 1442 raises endothelial calcium levels by inhibition of SERCA and activation of the IP3 pathway J. Mol. Cell Cardiol. 53 2012 567 577
45. T.O. Cheng Cardiovascular effects of Danshen Int. J. Cardiol. 121 2007 9 22
46. J. Meng Tasly pharmaceuticals: the leader of modern traditional Chinese medicine China Pharm. 18 2007 239 240
47. Z. Ying, and et al. Clinical efficacy of on coronary heart disease combined with angina pectoris J. Trad. Chin. Med. 28 2008 722 (in Chinese)
48. S. Gao, and et al. Cardiovascular actions and therapeutic potential of tanshinone IIA Atherosclerosis 220 2012 3 10
49. S. Qian, and et al. Effect of Salvia miltiorrhiza hydrophilic extract on the endothelial biomarkers in diabetic patients with chronic artery disease Phytother. Res. 26 2012 1575 1578
50. Q. Ren-an, and et al. Study of the protective mechanisms of compound Danshen Tablet (Fufang Danshen Pian) against myocardial ischemia/reperfusion injury via the Akt-eNOS signaling pathway in rats J. Ethnopharmacol. 156 2014 190 198
51. Y. Gao, and et al. Salvia miltiorrhiza (Danshen) inhibits L-type calcium current and attenuates calcium transient and contractility in rat ventricular myocytes J. Ethnopharmacol. 158PA 2014 397 403
52. J.J. Li, and et al. Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS) Ann. Med. 42 2010 231 240
53. C.P. Lin, and et al. Cholestin (Monascus purpureus rice) inhibits homocysteine-induced reactive oxygen species generation, nuclear factor-kappaB activation, and vascular cell adhesion molecule-1 expression in human aortic endothelial cells J. Biomed. Sci. 15 2008 183 196
54. S.F. Chu, and et al. New achievements in ginseng research and its future prospects Chin. J. Integr. Med. 15 2009 403 408
55. Y.L. Jia, and et al. Could ginseng-based medicines be better than nitrates in treating ischemic heart disease? A systematic review and meta-analysis of randomized controlled trials Complement Ther. Med. 20 2012 155 166
56. J. Yuan, and et al. 116 cases of coronary angina pectoris treated with powder composed of Radix Ginseng, Radix Notoginseng and Succinum J. Trad. Chin. Med. 17 1997 14 17
57. C.N. Gillis Panax ginseng pharmacology: a nitric oxide link? Biochem. Pharmacol. 54 1997 1 8
58. D. Zhang, and et al. Ginseng extract scavenges hydroxyl radical and protects unsaturated fatty acids from decomposition caused by iron-mediated lipid peroxidation Free Radic. Biol. Med. 20 1996 145 150
59. T.H. Kim, and S.M. Lee The effects of ginseng total saponin, panaxadiol and panaxatriol on ischemia/reperfusion injury in isolated rat heart Food Chem. Toxicol. 48 2010 1516 1520
60. +-ATPase inhibitors Acta Pharmacol. Sin. 32 2011 141 151
61. H. Chai, and et al. Ginsenosides block HIV protease inhibitor ritonavir-induced vascular dysfunction of porcine coronary arteries Am. J. Physiol. Heart Circ. Physiol. 288 2005 H2965 H2971
62. H.L. Kong, and et al. Anti-hypoxic effect of ginsenoside Rbl on neonatal rat cardiomyocytes is mediated through the specific activation of glucose transporter-4 ex vivo Acta Pharmacol. Sin. 30 2009 396 403
63. S. Chen, and et al. 454 EST analysis detects genes putatively involved in ginsenoside biosynthesis in Panax ginseng Plant Cell Rep. 30 2011 1593 1601
64. X.H. Liu, and et al. Leonurine improves ischemia-induced myocardial injury through antioxidative activity Phytomedicine 17 2010 753 759
65. X.H. Zeng, and et al. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am. J. Cardiol. 92 2003 173 176
66. S.S. Chatterjee, and B. Gabard Studies on mechanism of action of an extract of Ginkgo biloba, a drug used for treatment of ischemic vascular diseases Naunyn-Schmiedeberg Arch. Pharmacol. 321 1982 207
67. Y. Li, and C. Xu Cardioprotective efficacy of treatment with zhenju jiangya tablet and Leishi Danshen tablet in hypertensive patients Chin. Trad. Patent Med. 29 2007 795 (in Chinese)
68. L.Z. Yu, and C.R. Shi Effect of tanshinon II (A) on expression of different components in renin-angiotension system of left ventricles of hypertensive rats Zhongguo Zhong Yao Za Zhi 39 2014 1468 1472
69. H. Pang, and et al. The complex regulation of tanshinone IIA in rats with hypertension-induced left ventricular hypertrophy PloS One 9 2014 e92216
70. Y.J. Zhang, and et al. The ginsenoside Rg1 prevents transverse aortic constriction-induced left ventricular hypertrophy and cardiac dysfunction by inhibiting fibrosis and enhancing angiogenesis J. Cardiovas. Pharmacol. 62 2013 50 57
71. N. Qin, and et al. Total ginsenosides inhibit the right ventricular hypertrophy induced by monocrotaline in rats Biol. Pharm. Bull. 31 2008 1530 1535
72. S.M. Jeong, and et al. Stereospecificity of ginsenoside Rg3 action on ion channels Mol. Cells 18 2004 383 389
73. H.S. Hwang, and et al. Effects of hawthorn on cardiac remodeling and left ventricular dysfunction after 1 month of pressure overload-induced cardiac hypertrophy in rats Cardiovas. Drugs Ther. 22 2008 19 28
74. T.M. Woodruff, and et al. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke Mol. Neurodegener. 6 2011 11
75. T.V. Arumugam, and et al. Stroke and T-cells Neuromol. Med. 7 2005 229 242
76. S.L. Mehta, and et al. Molecular targets in cerebral ischemia for developing novel therapeutics Brain Res. Rev. 54 2007 34 66
77. X.Y. Ji, and et al. Salvia miltiorrhiza and ischemic diseases Acta Pharmacol. Sin. 21 2000 1089 1094
78. P. Ji, Z. Luo, and et al. Therapeutic effect of salvianolate on patients with acute ischemic cerebral stroke Pharm. Care Res. 10 2010 17 20 (in Chinese)
79. G. Xu, and et al. Danshen extracts decrease blood C reactive protein and prevent ischemic stroke recurrence: a controlled pilot study Phytother. Res. 23 2009 1721 1725
80. T.K. Kao, and et al. Tetramethylpyrazine reduces cellular inflammatory response following permanent focal cerebral ischemia in rats Exp. Neurol. 247 2013 188 201
81. M. Kim, and et al. Tetramethylpyrazine, a natural alkaloid, attenuates pro-inflammatory mediators induced by amyloid β and interferon-γ in rat brain microglia Eur. J. Pharmacol. 740 2014 504 511
82. L. He, and et al. Radix/rhizoma notoginseng extract (sanchitongtshu) for ischemic stroke: a randomized controlled study Phytomedicine 18 2011 437 442
83. L. Gao, and et al. Improvement of hematoma absorption and neurological function in patients with acute intracerebral hemorrhage treated with Xueshuantong J. Neurol. Sci. 323 2012 236 240
84. J. Kleijnen, and P. Knipschild Ginkgo biloba for cerebral insufficiency Brit. J. Clin. Pharmacol. 34 1992 352 358
85. P.L. Le Bars, and et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group JAMA 278 1997 1327 1332
86. 2+ current and shortening effect of action potential duration of Danshentong IIA in guinea pig ventricular myocytes Chin. Pharmacol. Bull. 14 1998 428 431
87. Q. Liang, and et al. Tanshinone IIA selectively enhances hyperpolarization-activated cyclic nucleotide-modulated (HCN) channel instantaneous current J. Pharmacol. Sci. 110 2009 381 388
88. F.F. Lam, and et al. Dihydrotanshinone, a lipophilic component of Salvia miltiorrhiza (danshen), relaxes rat coronary artery by inhibition of calcium channels J. Ethnopharmacol. 119 2008 318 321
89. F.F. Lam, and et al. Mechanisms of the dilator action of cryptotanshinone on rat coronary artery Eur. J. Pharmacol. 578 2008 253 260
90. Y. Wang, and et al. Mechanisms of the vasorelaxant effect of 1,5-dihydroxy-2,3-dimethoxy-xanthone, an active metabolite of 1-hydroxy-2,3,5-trimethoxy-xanthone isolated from a Tibetan herb, Halenia elliptica, on rat coronary artery Life Sci. 82 2008 91 98
91. R.R. Wang, and et al. The effects of paeoniflorin monomer of a Chinese herb on cardiac ion channels Chin. Med. J. (English) 124 2011 3105 3111
92. Y. Xing, and et al. The effects of allitridi and amiodarone on the conduction system and reverse use-dependence in the isolated hearts of rats with myocardial infarction J. Ethnopharmacol. 141 2012 674 684
93. W.H. Chen, and et al. Cellular electrophysiological effects of changrolin in isolated rat cardiac myocytes Eur. J. Pharmacol. 647 2010 139 146
94. L. Chen, and et al. Confirmation of a proarrhythmic risk underlying the clinical use of common Chinese herbal intravenous injections J. Ethnopharmacol. 142 2012 829 835
95. S. Dimmeler, and et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation Nature 399 1999 601 605
96. A.G. Herman, and S. Moncada Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis Eur. Heart J. 26 2005 1945 1955
97. J.Y. Park, and et al. The mechanism of vasorelaxation induced by Schisandra chinensis extract in rat thoracic aorta J. Ethnopharmacol. 121 2009 69 73
98. S.N. Jin, and et al. The mechanism of vasorelaxation induced by ethanol extract of Sophora flavescens in rat aorta J. Ethnopharmacol. 137 2011 547 552
99. C. Pan, and et al. Panax notoginseng and its components decreased hypertension via stimulation of endothelial-dependent vessel dilatation Vascul. Pharmacol. 56 2012 150 158
100. J.Y. Park, and et al. Gomisin J from Schisandra chinensis induces vascular relaxation via activation of endothelial nitric oxide synthase Vascul. Pharmacol. 57 2012 124 130
101. M.J. Bernardes, and et al. Hypotensive effect of Aspidosperma subincanum Mart. in rats and its mechanism of vasorelaxation in isolated arteries J. Ethnopharmacol. 145 2013 227 232
102. K. Uchida, and et al. Expression of platelet-derived growth factor B-chain in neointimal smooth muscle cells of balloon injured rabbit femoral arteries Atherosclerosis 124 1996 9 23
103. X. Yang, and et al. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation Arterioscler. Thromb. Vasc. Biol. 26 2006 85 90
104. B. Jiang, and et al. Differential effects of platelet-derived growth factor isotypes on human smooth muscle cell proliferation and migration are mediated by distinct signaling pathways Surgery 120 1996 427 431 discussion 432
105. S. Lee, and et al. Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model Atherosclerosis 186 2006 29 37
106. K.W. Liang, and et al. Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury Biochem. Pharmacol. 71 2006 806 817
107. K.W. Liang, and et al. Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells Eur. J. Pharmacol. 590 2008 343 354
108. S.L. Pan, and et al. Esculetin inhibits Ras-mediated cell proliferation and attenuates vascular restenosis following angioplasty in rats Biochem. Pharmacol. 65 2003 1897 1905
109. T.J. Kim, and et al. Corynoxeine isolated from the hook of Uncaria rhynchophylla inhibits rat aortic vascular smooth muscle cell proliferation through the blocking of extracellular signal regulated kinase 1/2 phosphorylation Biol. Pharm. Bull. 31 2008 2073 2078
110. C.Y. Moon, and et al. Protocatechuic aldehyde inhibits migration and proliferation of vascular smooth muscle cells and intravascular thrombosis Biochem. Biophys. Res. Commun. 423 2012 116 121
111. L.H. Dong, and et al. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRbeta-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia Cell Res. 20 2012 1252 1262
112. J.W. Hoffman Jr., and et al. Myocardial reperfusion injury: etiology, mechanisms, and therapies J. Extra Corpor. Technol. 36 2004 391 411
113. N.S. Dhalla, and et al. Evidence for the role of oxidative stress in acute ischemic heart disease: a brief review Can. J. Cardiol. 15 1999 587 593
114. L. Cominacini, and et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species J. Biol. Chem. 275 2000 12633 12638
115. G. Poli, and et al. Oxidative stress and cell signalling Curr. Med. Chem. 11 2004 1163 1182
116. X.L. Niu, and et al. Tanshinone II-A inhibits low density lipoprotein oxidation in vitro Free Radic. Res. 33 2000 305 312
117. L.N. He, and et al. Protective effect of tanshinone on injured cultured PC12 cells in vitro Zhongguo Zhong Yao Za Zhi 26 2001 413 416
118. G.Y. Zhou, and et al. Protective effects of sodium tanshinone IIA sulphonate against adriamycin-induced lipid peroxidation in mice hearts in vivo and in vitro Pharmacol. Res. 40 1999 487 491
119. Y.I. Li, and et al. Tanshinone IIA reduces macrophage death induced by hydrogen peroxide by upregulating glutathione peroxidase Life Sci. 83 2008 557 562
120. V.S. Panda, and S.R. N Evaluation of cardioprotective activity of Ginkgo biloba and Ocimum sanctum in rodents Altern. Med. Rev. 14 2009 161 171
121. X. Yang, and et al. Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulating inflammatory responses, reducing oxidative stress and anti-proliferative J. Ethnopharmacol. 157 2014 105 113
122. J. Chen, and et al. Vascular protective potential of the total flavanol glycosides from Abacopteris penangiana via modulating nuclear transcription factor-kappaB signaling pathway and oxidative stress J. Ethnopharmacol. 136 2011 217 223
123. H.B. Zhang, and et al. Flavonoids from Inula britannica reduces oxidative stress through inhibiting expression and phosphorylation of p47(phox) in VSMCs Pharm. Biol. 49 2011 815 820
124. H. He, and et al. Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats J. Pharm. Pharmacol. 60 2008 115 123
125. J.K. Li, and et al. Protective effects of farrerol against hydrogen-peroxide-induced apoptosis in human endothelium-derived EA.hy926 cells Can. J. Physiol. Pharmacol. 91 2013 733 740
126. A.Y. Woo, and et al. Andrographolide up-regulates cellular-reduced glutathione level and protects cardiomyocytes against hypoxia/reoxygenation injury J. Pharmacol. Exp. Ther. 325 2008 226 235
127. J. Narula, and et al. Apoptosis in myocytes in end-stage heart failure N. Engl. J. Med. 335 1996 1182 1189
128. A. Saraste, and et al. Apoptosis in human acute myocardial infarction Circulation 95 1997 320 323
129. K. Doyama, and et al. Tumour necrosis factor is expressed in cardiac tissues of patients with heart failure Int. J. Cardiol. 54 1996 217 225
130. T. Kubota, and et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha Circ. Res. 81 1997 627 635
131. M.R. Sayen, and et al. Calcineurin transgenic mice have mitochondrial dysfunction and elevated superoxide production Am. J. Physiol. Cell Physiol. 284 2003 C562 C570
132. J. Wang, and et al. Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression Proc. Natl. Acad. Sci. U. S. A. 98 2001 4038 4043
133. Y.H. Song, and et al. Ethanol extract from Epimedium brevicornum attenuates left ventricular dysfunction and cardiac remodeling through down-regulating matrix metalloproteinase-2 and -9 activity and myocardial apoptosis in rats with congestive heart failure Int. J. Mol. Med. 21 2008 117 124
134. L. Yiming, and et al. Neuroprotective effects of breviscapine against apoptosis induced by transient focal cerebral ischaemia in rats J. Pharm. Pharmacol. 60 2008 349 355
135. C.Y. Huang, and et al. Protective effect of Danggui (Radix Angelicae Sinensis) on angiotensin II-induced apoptosis in H9c2 cardiomyoblast cells BMC Complement. Altern. Med. 14 2014 358
136. C. Liu, and et al. 3,5-Dimethoxy-4-(3-(2-carbonyl-ethyldisulfanyl)-propionyl)-benzoic acid 4-guanidino-butyl ester: a novel twin drug that prevents primary cardiac myocytes from hypoxia-induced apoptosis Eur. J. Pharmacol. 700 2013 118 126
137. M. Aikawa, and et al. Cardiovascular inflammation Int. J. Inflam. 2012 2012 904608
138. D. Segers, and et al. Atherosclerotic plaque stability is affected by the chemokine CXCL10 in both mice and humans Int. J. Inflamm. 2011 2011 936109
139. K.L. Sider, and et al. Animal models of calcific aortic valve disease Int. J. Inflamm. 2011 2011 364310
140. P. Luo, and et al. Scutellarin isolated from Erigeron multiradiatus inhibits high glucose-mediated vascular inflammation Yakugaku Zasshi 128 2008 1293 1299
141. W. Chen, and et al. Effects of Astragalus polysaccharides on chymase, angiotensin-converting enzyme and angiotensin II in diabetic cardiomyopathy in hamsters J. Int. Med. Res. 35 2007 873 877
142. P. Zhao, and et al. Chinese medicinal herb Radix Astragali suppresses cardiac contractile dysfunction and inflammation in a rat model of autoimmune myocarditis Toxicol. Lett. 182 2008 29 35
143. J. Yang, and et al. Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-small ka, CyrillicB signaling pathway in isoproterenol-induced myocardial hypertrophy J. Ethnopharmacol. 150 2013 1062 1070
144. S.S. Chan, and et al. Synergistic interaction between the Ligusticum chuanxiong constituent butylidenephthalide and the nitric oxide donor sodium nitroprusside in relaxing rat isolated aorta J. Ethnopharmacol. 122 2009 308 312
145. D.M. Zhang, and et al. In-vivo and in-vitro studies on the effect of Huang-Lian-Jie-Du-Tang on nimodipine transport across rat blood-brain barrier J. Pharm. Pharmacol. 59 2007 1733 1738
146. R.Z. Shi, and et al. Demethylbellidifolin prevents nitroglycerin tolerance via improved aldehyde dehydrogenase 2 activity Planta. Med. 75 2009 1476 1481
147. P.K. Singal, and N. Iliskovic Doxorubicin-induced cardiomyopathy N. Engl. J. Med. 339 1998 900 905
148. C.E. Myers, and et al. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response Science 197 1977 165 167
149. J.H. Doroshow, and K.J. Davies Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical J. Biol. Chem. 261 1986 3068 3074
150. L. Liu, and et al. Protective effect of saponins from Panax notoginseng against doxorubicin-induced cardiotoxicity in mice Planta Med. 74 2008 203 209
151. A. Tachjian, and et al. Use of herbal products and potential interactions in patients with cardiovascular diseases J. Am. Coll. Cardiol. 55 2010 515 525
152. M.K. Matthews Association of Ginkgo biloba with intracerebral hemorrhage Neurology 50 1998 1933 1934
153. Y. Taki, and et al. Ginkgo biloba extract attenuates warfarin-mediated anticoagulation through induction of hepatic cytochrome P450 ensymes by bilobalide in mice Phytomedicine 19 2012 177 182
154. R. Ashraf, and et al. Effects of Allium sativum (garlic) on systolic and diastolic blood pressure in patients with essential hypertension Pak. J. Pharm. Sci. 26 2013 859 863
155. J. Vesper, and et al. Efficacy of Ginkgo biloba in 90 outpatients with cerebral insufficiency caused by old age results of a placebo-controlled double-blind trial Phytomedicine 1 1994 9 16
156. S. Meng, and et al. Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention Clin. Exp. Pharmacol. Physiol. 39 2012 406 411
157. Z.Q. Chen, and et al. Effect of tetramethylpyrazine on platelet activation and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention Zhongguo Zhong Xi Yi Jie He Za Zhi 27 2007 1078 1108
158. G.H. Fan, and et al. Effect of ligustrazine on plasma lipid peroxidation, superoxide dismutase of the coronary heart disease Zhongguo Zhong Xi Yi Jie He Za Zhi 14 1994 26 27